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Abstract
Background: Clomiphene citrate (CC) is one of the widely used drugs as an ovulation
stimulant, but its adverse effects on the endometrium results in lowering down the
pregnancy rate. Endometrium CD98 is also important in the process of implantation.
Objective: To evaluate the immunohistochemistry expression levels of endometrial
CD98 following injection of CC with and without Human chorionic gonadotropin (HCG)
in ovariectomized and non-ovariectomized rats.
Materials and Methods: Seventy two (12-14 wk old) female Wistar rats were randomly
divided into two groups (n = 36): (a) ovariectomized and (b) non-ovariectomized. Each
group was further divided into six subgroups (n = 6/each): (1) CC 10 mg/kg, (2) CC 20
mg/kg, (3) HCG, (4) CC 10 mg/kg with HCG, (5) CC 20 mg/kg with HCG, and (6) control.
The experimental subgroups received a single dose of CC (daily, five days) and HCG
(after the last injection of CC) alone or in combination. Immunohistochemistry staining
was performed on paraffin-embedded endometrial tissues to evaluate the expression
levels of CD98.
Result: Animals undergoing ovariectomy presented a significantly lower expression
level of endometrial CD98 (p < 0.001) when compared with non-ovariectomized in
the same condition that groups were subdivided. There was also a dose-dependent
reduction (p<0.001) in the expression of CD98 in non-ovariectomized subgroupswhen
compared with control group. In addition, injection of HCG following treatment with CC
improved its expression.
Conclusion: It was concluded that CC impairs CD98 expression in endometrium and
this impairment is intensified with the removal of the ovary. Also, an injection of HCG
following treatment with CC can slightly improve the expression of CD98.
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1. Introduction
Clomiphene citrate (CC) is advised to be the
first-line treatment for polycystic ovary syndrome
(PCOS) (1) and other subfertility illnesses associated
with oligo-ovulation (2) since it is effective, low-cost,
easily available, and themajority of women tolerate
it well (1); it is increase the ovulation rate (60-85%)
but decrease the pregnancy rate (only by about
20%) due to its adverse effects on the endometrium
(2). In addition, histological and biochemical studies
confirm these detrimental effects of CC (3, 4).
Several studies have revealed that CC, depending
on the endogenous hormonal environment can
be an estrogen agonist either an antagonist on
estrogen-sensitive tissues (5) so that the public
use of the intrauterine insemination (IUI) almost is
owing anti-oestrogenic effects of CCon the cervical
mucus (4).
Also, according to the previous studies, the
administration of HCG following pre-stimulation
with CC inhibits detrimental effects of CC on the
endometrial competence and therefore increases
the development, proliferation, and thickness of
endometrium (6).
A biochemical, immunohistological, and func-
tional study has revealed that CD98 is a key factor
of human endometrial receptivity, as its expres-
sion is strongly regulated during the implantation
window (7, 8). Implantation window is a specific
period of the uterine cycle when the endometrium
is highly receptive for blastocyst (9) and takes
place for 4-5 days after progesterone secretion and
lasts about five days. It is also framed by the co-
expression of three members of the integrin family,
α1β1, α4β1, and αvβ3 (10) and steroidal ovarian
hormones (11). At this stage, the endometrium
undergoes morphological [modifications of the
plasmamembrane (12) and cytoskeleton (13)], struc-
tural and biochemical changes under the influence
of specific gene regulation. CD98/4F2/FRP-1(fusion
regulatory protein-1) was found in human and
mouse lymphocytes in 1981 and described as an
activated antigen (14). It is a multifunctional protein
(15) and at least two distinct functions have been
descripted for its heavy chain, transportation of
amino acids (16), and correlation with β1 and β3
integrins which cause an increase in their affinity
for ligands and integrin signaling regulation (17, 18).
CD98 has also involved in cell–cell interactions
directly (19) and is necessary for cell adhesion
and fusion which is essential in placenta devel-
opment. (20). It is also determined that distrac-
tion of the CD98 gene increases the mortality of
mouse embryos (21). All cell types express CD98
except for the platelets (22), stromal and epithelial
cells of endometrium express it during the mid-
secretory phase as well. It locates at the apical
surface of endometrial epithelial cells and corre-
lates with tetraspanin-enriched microdomains in
a hormone-dependent organization, which relates
with blastocyst adhesion and it is now clear that
decreasing of expression levels of CD98 plasma
membrane causes failure of blastocyst adhesion
(7) and may be one of the results of recurrent
implantation failure in IVF treatment receiving
cases (23).
Although there are evidences of importance
of CD98 in implantation and it is also obvious
that hormonal changes can alter CD98 expression
levels, effects of ovulation inductors like CC on
endometrial CD98 expression has not been stud-
ied. The current research was planned with that
need in mind.
2. Materials and Methods
2.1. Animals and drug treatment
In this experimental study, 72 (12-14 wk old)
virgin female Wistar rats (Ratus norvegicus) were
obtained from the Central Animal Unit of the
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Iran University of Medical Sciences; CC and HCG
were purchased from Sigma Chemical Company
(St Louis, MO, USA) and LG Life Company (LG
Life Sciences, South Korea), respectively. Solvents
were analytically graded and used without further
purification.
Animals were randomly divided into two main
groups (n = 36/each): (I) ovariectomized and (II) non-
ovariectomized. Animals were kept under standard
laboratory conditions, under a 12 hr light/dark cycle
at room temperature of 22 ± 2°C and had free
access to pelleted food and tap water. Ovariec-
tomized group went under bilateral ovariectomy as
described by Hosie and colleagues (11) and were
allowed 3-4 wk to recover before any treatments
after surgery to make sure that there are no
ovarian hormones left in the circulating system
(9). Both ovariectomized and non-ovariectomized
groups were divided into six subgroups (n =
6/each):
(a) cc10, (b) cc20, (c) cc10 + HCG, (d) cc20
+ HCG, (e) HCG and control, which were kept
without intervention. Animals of (a), (b), (c), and (d)
subgroups received 10/20 mg/kg of CC by daily
intraperitoneal injection at 10:00 am for five days.
The (e) subgroup received a single dose of HCG (10
I.U. /0-4 ml 0-154 m-NaCl) at 10:00 am. The (c) and
(d) subgroups both received a single dose of HCG
after the last injection of CC.
2.2. Histological study
2.2.1. Sample preparation
All animals were sacrificed on the morning
of the day after mating (a vaginal plaque and
smear observed) approximately 24-26 hr after
the last drug injection using a lethal dose of
ketamine (150 mg/kg) and Xylasin (15 mg/kg). The
left uterine horns were excised, placed in 0.1
M of phosphate buffered saline [(pH 7.4 (Gibco
life tech. tablets)], cleaned of fat, cut into 1-cm
pieces, and then tissues were fixed in 10% formalin
solution, paraffin embedded, then cut to 5-μm
thick sections (transverse serial sections); deparaf-
finized with xylene and rehydrated using graded
ethanol.
2.2.2. Immunohistochemistry
A primary anti-CD98 antibody and an Immuno
Cruz𝑇𝑀 ABC Staining Kit (Santa Cruse, USA),
used in case and control groups for immunohisto-
chemistry staining. Tissue sections were blocked
in 10-mM sodium citrate buffer, pH 6.0 for 10
min at 90°C, and endogenous peroxidase activity
was suppressed by incubation with 0.1% H2O2 in
absolute methanol for 5 min at room temperature
and a 6-min rehydration in phosphate buffered
saline (PBS). After the incubation with blocking
serum for 60 min at room temperature (1.5% normal
goat serum), sections were incubated with the
primary antibody (1:100) diluted in PBS at 4°C
overnight. Negative controls were incubated with-
out primary antibody. A PBS rinse was followed
by the treatment with the secondary antibody (a
biotinylated anti-rabbit IgG antibody) for 30 min.
Sections then washed and incubated with avidin:
biotinylated horseradish peroxidase macromolec-
ular complex for 30 min. DAB (Diaminobanzidin)
was added as the choromogene and incubated
for 8 min to complete the reaction and to visual-
ize the immunostaining. As a final step, sections
sections counterstained with hematoxylin for 5
min, dehydrated in a graded series of ethanol,
and cleared with xylene. A coverslip was placed
over permount for evaluation by light microscopy.
The endometrial blood staining used as positive
internal controls as well. Images were captured
at 400× magnification using a Zeiss LSM 5 light
microscope evaluated by two treatment blinded
observers. The assessment of staining intensity
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and distribution in endometrial epithelium was
made using the semi-quantitative histologic score
(HSCORE) system. HSCORE was calculated using
the following equation:
𝐻score =∑𝑃𝑖(𝐼 + 1)/100
Where i = intensity of staining with a value of 1,
2, or 3, (weak, moderate, or strong, respectively)
and Pi = the percentage of stained endometrial
epithelial cells for each intensity, varying from 0-
100%.
Low intra-observer (r = 0.983; p < 0.0001) and
inter-observer (r = 0.994; p< 0.0001) differences for
HSCORE in uterine tissues have been previously
reported using this technique. The numerical cut-
off for a negative result for the CD98 was an
HSCORE of ≤ 0.7, based on previous ROC analysis
(24).
2.3. Ethical consideration
All animal care and experimental procedures
were carried out in order to avoid or reduce pain
or stress to a lab animal whenever possible and
approved in the approval letter no.1862.
2.4. Statistical analysis
Statistical calculations were performed using
SPSS software (Statistical Package for Social Sci-
ence, version 16.0, SPSS Inc, and Chicago, IL, USA).
Statistical significance between groups was evalu-
ated using one-way ANOVA analysis of variance.
The differences between groups were determined
by the Tukey test. Results were presented as mean
± SD with p < 0.05 considered to be statistically
significant.
3. Results
3.1. Expression of CD98 on endome-
trial epithelium in ovariectomized
rats
Table I shows that there is no significant differ-
ence between CD98 expression levels in ovariec-
tomized subgroups with the exception of CC10
+ HCG and HCG group (p < 0.0001) which indi-
cates that HCG can improve adverse effects of
ovariectomy only when CC is not used or is used
in low dosage. Table II also shows that CD98
expression levels are significantly higher in non-
ovariectomized subgroups compared to ovariec-
tomized subgroups with the same treatment which
shows the importance of ovarian hormones, but
when CC is used in higher dosage, the presence or
lack of ovary makes no difference in the expression
levels.
3.2. Expression of CD98 on
endometrial epithelium in non-
ovariectomized (normal) rats
The comparison of the CD98 expression in the
non-ovariectomized rats exposed to CC with and
without HCG and HCG alone with control group
is summarized in Table III. Overall there was a
statistically significant decrease (p < 0.0001) in the
expression of the CD98 in the non-ovariectomized
rats undergoing treatment with CC (10, 20 mg/kg)
alone and in combination with HCG compared to
the control group. Administration of HCG following
CC induced the expression, but it could not fully
reverse it to normal expression status. Normal
expression levels of CD98 were only observed in
the subgroup treated with HCG alone (Figure 1).
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3.3. Expression of CD98 on endome-
trial epithelium was dependent to
CC dosage
Table IV shows a significant decrease in CD98
with increasing dosage of CC from 10 to 20 mg/kg
in all subgroups of non-ovariectomized group and
subgroups that received HCG with CC in the
ovariectomized group that shows that adverse
effects of CC are dose-dependent.
3.4. Expression of CD98 on
endometrial epithelium due to
HCG administration after pre-
stimulation by CC
HCG significantly affects the expression of the
CD98 in all subgroups when CC is used in a lower
dosage, but the higher dosage of CC prevents the
improvement, especially in a non-ovariectomized
group (Table V).
Table I. Expression levels of endometrial epithelium CD98 in ovariectomized subgroups exposed to CC with and without HCG,
and comparison with control group
Subgroups (each, n = 6) Ovariectomized group Control group (n = 6) p𝑎
CC10 (mg/kg) 1.12 ± 0.30 0.99
CC20 (mg/kg) 1 0.99
HCG (7.5IU/kg) 2.24 ± 0.51 0.0001
CC10(mg/kg) + HCG (7.5I.U) 1.78 ± 0.63 0.0001
CC20(mg/kg) + HCG (7.5I.U) 1.15 ± 0.21
1.07 ± 0.71
0.99
𝑎Note: a values represent mean and the associated standard deviation; p < 0.05 is considered statically significant
One-way ANOVA and Tukey tests were used to determine significance
CC: clomiphene citrate HCG: human chorionic gonadotropin
Table II. Expression levels of endometrial epithelium CD98 in ovariectomized and non-ovariectomized subgroups exposed to CC
with and without HCG
Subgroups(each, n = 6) Ovariectomized group Non-ovariectomized group p𝑎
CC10 (mg/kg) 1.12 ± 0.30 1.86 ± 0.22 0.001
CC20 (mg/kg) 1 1.22 ± 0.28 0.972
HCG (7.5IU/kg) 2.24 ± 0.51 4 0.0001
CC10(mg/kg) + HCG (7.5I.U) 1.78 ± 0.63 2.69 ± 0.38 0.001
CC20(mg/kg) + HCG (7.5I.U) 1.15 ± 0.21 1.80 ± 0.82 0.054
𝑎Note: a values represent mean and the associated standard deviation; p < 0.05 is considered statically significant
One-way ANOVA and Tukey tests were used to determine significance
CC: clomiphene citrate HCG: human chorionic gonadotropin
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Table III. Expression levels of endometrial epithelium CD98 in non-ovariectomized subgroups exposed to CC with and without
HCG and comparison with control group
Subgroups (each, n = 6) Non- ovariectomized group Control group (n = 6) p𝑎
CC10 (mg/kg) 1.86 ± 0.22 0.0001
CC20 (mg/kg) 1.22 ± 0.28 0.0001
HCG (7.5IU/kg) 4 1
CC10(mg/kg) + HCG (7.5I.U) 2.69 ± 0.38 0.0001
CC20(mg/kg) + HCG (7.5I.U) 1.80 ± 0.82
3.93 ± 0.35
0.0001
𝑎Note: a values represent mean and the associated standard deviation; p < 0.05 is considered statically significant
One-way ANOVA and Tukey tests were used to determine significance
CC: clomiphene citrate HCG: human chorionic gonadotropin



















Mean ± SD 1.12 ± 0.30 1 1.78 ± 0.63 1.15 ± 0.211 1.86 ± 0.22 1.22 ± 0.28 2.69 ± 0.38 1.80 ± 0.82
P 0.96 0.002 0.005 0.0001
Note: A value represent mean and the associated standard deviation; (p < 0.05) is considered statistically significant; a dose-
dependent decrease in CD98 was significantly observed with increasing doses of CC from 10 to 20 mg/kg
One-way ANOVA and Tukey test were used to determine significance
CC: clomiphene citrate HCG: human chorionic gonadotropin
Table V. Changes in the expression of endometrial epithelium CD98 due to the administration of HCG following different doses
of CC
Ovariectomized Non-ovariectomized

















Mean ± SD 1.12 ± 0.30 1.78 ± 0.63 1 1.15 ± 0.211 1.86 ± 0.22 2.69 ± 0.38 1.22 ± 0.28 1.80 ± 0.82
P 0.0001 0.016 0.001 0.919
Note: A value represent mean and the associated standard deviation; (p < 0.05) is considered statistically significant
One-way ANOVA and Tukey test were used to determine significance
CC: clomiphene citrate HCG: human chorionic gonadotropin
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Figure 1. Microscopic images (10×) of rat uterus tissues in different groups one day after mating; consider the expression levels
due to chromogenic severity of the apex of endothelial cells.
I. Ovariectomized subgroup: (a) CC10 group; (b) CC20 group; (c) CC10 + HCG group; (d) CC20 + HCG group; (e) HCG group; (control)
Control group.
II. Non-ovariectomized subgroup: (a’) CC10 group; (b’) CC20 group; (c’) CC10 + HCG group; (d’) CC20 + HCG group; (e’) HCG group;
(control’) Control group.
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4. Discussion
As our best knowledge this is the first exper-
imental study that shows the expression of
CD98 on endometrial epithelium in adult female
rats (ovariectomized and non-ovariectomized) after
exposure to two doses of CC and HCG alone
and combined. Our results revealed a significant
decrease in the expression of CD98 after treating
with CC alone and in combination with HCG. Also,
the adverse effects of CC on the expression levels
in ovariectomized rats were more prominent. In
addition, the administration of HCG following a
lower dose of CC (10 mg/kg) significantly increased
the expression of the CD98, but it could not fully
reverse it to the normal status. Additionally, the
expression of endometrial epithelium CD98 in both
ovariectomized and non-ovariectomized showed
that a CC dose-dependentmanner and low dosage
was less destructive. Finding the molecular basis
of embryonic implantation is very important clin-
ically and biologically (7). A number of studies
have shown that molecular control of endome-
trial receptivity involves the interface between a
diversity of molecules including lectins, mucins,
glycoproteins, and other endometrial secretory
products (25). One of these molecules is CD98,
a member of tetraspanin-enriched microdomains
family, which has been shown to be expressed
in human endometrial epithelium and appears to
be an important aspect of human endometrial
receptivity during the implantation window (7).
The results of Domínguez and colleagues are
the same as that of Thomas and colleagues that
showed that TGFβ (Transforming Growth Factor)
and gonadotropins significantly reduced CD98 (in-
vitro) and integrins (α1β1, α4β1 and αvβ3) expres-
sion, respectively. Also, Meyer and coworkers
showed a reduction in the expression of integrins
in women who underwent ovulation induction (26)
which is consistent with the expression of CD98
in our animals treated with CC, although the
experimental design with respect to the case, drug,
dosage, and duration of treatments was not similar.
The reduction can be explained by a blockage of
estradiol 2 [(E2)-induced endometrial epithelial cell
proliferation], transcriptional functions of a gene
that is responsible for creating different parts of
estrogen receptor (ER), formation of ER complex
with SRC-1(steroid receptor co-activator-1), and inhi-
bition of mitosis in proliferative phase by CC (27).
However, morphometric evaluation of glandular
and stromal structures showed a clear reduction of
endometrial development after several treatment
protocols (23, 27). The endometrial epithelium may
also be affected at molecular levels. Modification in
estrogen levels may cause a failure in endometrial
receptivity (28). Our results regarding a decrease
in CD98 expression of ovariectomized animals
treated with CC and HCG alone and in combination
are consistent with the results of a previous study
by Carpenter and colleagues, who showed that
ovariectomy by disturbing the different parts of
activin-follistatin system, may negatively affect the
growth and development of endometrial glands in
ovariectomized animals (29). The ovarian factors
that adjust uterine growth and endometrial adeno-
genesis are not clearly defined, although there are
evidences that describe follistatin and inhibin or
activin as involved factors (30).
In addition, the maximum expression level in
Ovariectomized subgroups belonged to the HCG
subgroup, but this amount was significantly less
than the normal groups. Thus, the results of this
study indicated that a single dose of HCG is
unable to repair the adverse effects on CD98
expression due to the lack of steroidal hormones
of the ovary and their role in endometrial prolif-
eration. Our results suggest that normal ovaries
are necessary for normal expression of CD98;
however, additional studies are needed to clarify
the effects of CC and HCG alone and combina-
tion of following ovariectomy on the expression
of CD98. It has been suggested that CC may
increase serum levels of estradiol and proges-
terone and decrease endometrial epithelium there
upon (4) and a higher CC dosage usually resulted
in great diverging morphological alterations. We
found that the expression of CD98 was related to
CC dosage when used alone in Ovariectomized
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subgroups and with HCG in both Ovariectomized
and non-Ovariectomized subgroups; this confirms
the results of a previous studies that declared
a dose-related effect of the CC on endometrial
structure and steroid concentrations (31). Also, our
findings were similar to the results of a study that
showed that increased doses of CC from 1, 5 to
10 µ M in the culture medium of endometrial cells
interrupted natural proliferation andmodification of
cells (32).
The conflicting results of CC may be due to
its antiestrogenic effects on endometrium as well
as cervix. In our study, HCG failed to reverse the
expression levels to normal values following pre-
treatment with CC; also, the data revealed that
a single dose of HCG alone markedly increased
the expression of CD98. In addition, HCG sig-
nificantly affects the expression of the CD98 in
the both experimental subgroups that received
a lower dose of CC (10mg/kg). These results
are in agreement with a report by Dominguez
and colleagues, who detected that the greatest
increase observed upon the treatment with both
progesterone and 17-β-estradiol, and HCG treat-
ment is also able to induce the expression of
CD98 in primary endometrial epithelial cells (7). A
possible explanation for this could be that during
the window of implantation, HCG exerts a positive
influence on endometrial epithelium to secret sev-
eral growth factors (interleukin-11, CXCL10, granu-
locyte macrophage colony-stimulating factor) that
resulted in more proliferation of endometrium,
increase in reception and development of tro-
phoblast (33). Also, it may particularly induce
decidualization by rising cAMP synthesis (34).
In addition, it has been suggested that multiple
paracrine factors (as tissue remodeling parameters)
related to the endometrial differentiation include;
insulin-like growth factor-binding protein-1(IGFBP-
1), vascular endothelial growth factor (VEGF), and
matrix metalloproteinase-9 (MMP-9) can be mod-
ulated by HCG administration during the luteal
phase (30). Additionally, it is confirmed that
HCG can modulate the secretion of cytokines
and growth factors thorough LH receptors and
improve endometrial epithelium and implantation
(20, 35).
5. Conclusion
Our results indicated that CC impairs CD98
expression in endometrium and this impairment
is intensified with the removal of the ovary.
Also, it appears that HCG has slightly stimulatory
responses on CD98 gene expression, thus it can
slightly elevate its expression depending on the
CC dose. In addition, the dose 20 mg/kg has
the most negative effects on the gene expression
of CD98. More studies are recommended in this
field to investigate other molecular and cellular
mechanisms altered by ovary inductive treatments.
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